KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Free Cash Flow (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Free Cash Flow for 18 consecutive years, with $848.3 million as the latest value for Q1 2026.

  • For Q1 2026, Free Cash Flow rose 3.98% year-over-year to $848.3 million; the TTM value through Mar 2026 reached $4.1 billion, up 32.6%, while the annual FY2025 figure was $4.1 billion, 11.35% up from the prior year.
  • Free Cash Flow hit $848.3 million in Q1 2026 for Regeneron Pharmaceuticals, down from $922.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $2.0 billion in Q1 2022 and bottomed at $336.3 million in Q2 2024.
  • Average Free Cash Flow over 5 years is $993.7 million, with a median of $922.0 million recorded in 2025.
  • Year-over-year, Free Cash Flow crashed 85.17% in 2022 and then surged 255.31% in 2025.
  • Regeneron Pharmaceuticals' Free Cash Flow stood at $1.6 billion in 2022, then crashed by 46.53% to $838.3 million in 2023, then grew by 26.83% to $1.1 billion in 2024, then dropped by 13.28% to $922.0 million in 2025, then fell by 7.99% to $848.3 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at $848.3 million, $922.0 million, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.